Finding ways to improve heart function and prevent dangerous heart rhythms after a heart attack
Novel Mechanisms that Restore Cardiac Parasympathetic Activity Limits Arrhythmias and Cardiac Dysfunction After Myocardial Infarction
This study is looking at how a nasal spray of oxytocin might help improve heart health and prevent dangerous heart rhythms after a heart attack, aiming to find a safe way to help people at risk of sudden cardiac death.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10604331 on NIH RePORTER |
What this research studies
This research investigates how to enhance parasympathetic activity in the heart to prevent life-threatening arrhythmias and cardiac dysfunction following a heart attack. The approach focuses on using intranasal oxytocin to stimulate the parasympathetic nervous system, which may help restore balance and improve heart health. By studying animal models, the researchers aim to identify effective methods to increase this activity safely and feasibly in patients at risk. The ultimate goal is to develop a treatment that can significantly reduce the risk of sudden cardiac death.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals who have experienced a myocardial infarction and are at risk for arrhythmias.
Not a fit: Patients who have not experienced a heart attack or do not have risk factors for arrhythmias may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly lower the risk of sudden cardiac death and improve heart function in patients after a heart attack.
How similar studies have performed: Previous research has shown promising results with similar approaches, particularly in enhancing parasympathetic activity in patients with sleep apnea.
Where this research is happening
Washington, United States
- George Washington University — Washington, United States (Active)
Researchers
- Principal investigator: Mendelowitz, David — George Washington University
- Study coordinator: Mendelowitz, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.